The supply of glucagon-like peptide-1 (GLP-1) receptor agonists is not expected to return to normal until at least the end of 2024, the Department of Health and Social Care for England has warned,1 given the shortages caused by increased demand and off-label use.
Clinicians have been told not to prescribe GLP-1 agonists …